Epsilon Healthcare Limited
Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in two segments, Contract Development and Manufacturing Activities; and Telehealth Medical Practice Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmace… Read more
Epsilon Healthcare Limited (HDRPF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: -0.080x
Based on the latest financial reports, Epsilon Healthcare Limited (HDRPF) has a cash flow conversion efficiency ratio of -0.080x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.21 Million) by net assets ($15.11 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Epsilon Healthcare Limited - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Epsilon Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Epsilon Healthcare Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Epsilon Healthcare Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
IMPERIAL TOBACCO - Dusseldorf Stock Exchang
DU:ITB
|
N/A |
|
Inter Industries
TA:ININ
|
0.051x |
|
SANDVIK (SVKB.SG)
STU:SVKB
|
0.075x |
|
Rexel SA
BE:E7V
|
N/A |
|
MUEHLBAUER HOLDING - Dusseldorf Stock Exchang
DU:MUB
|
N/A |
|
OSAKA GAS - Dusseldorf Stock Exchang
DU:OSA
|
N/A |
|
GS Holdings Corp. Pfd. Series 1
KQ:078935
|
N/A |
|
NEURONES (NE9.SG)
STU:NE9
|
0.031x |
Annual Cash Flow Conversion Efficiency for Epsilon Healthcare Limited (2016–2024)
The table below shows the annual cash flow conversion efficiency of Epsilon Healthcare Limited from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $15.11 Million | $-2.11 Million | -0.139x | +49.70% |
| 2022-12-31 | $9.27 Million | $-2.57 Million | -0.277x | +0.04% |
| 2021-12-31 | $19.57 Million | $-5.43 Million | -0.277x | +19.21% |
| 2020-12-31 | $25.32 Million | $-8.69 Million | -0.343x | +2.43% |
| 2019-12-31 | $22.32 Million | $-7.86 Million | -0.352x | -68.97% |
| 2018-12-31 | $28.09 Million | $-5.85 Million | -0.208x | -136.88% |
| 2017-12-31 | $21.36 Million | $-1.88 Million | -0.088x | -574.77% |
| 2016-12-31 | $11.34 Million | $-147.81K | -0.013x | -- |